Literature DB >> 29979092

Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.

Yader Sandoval1, Stephen W Smith2, Anne Sexter3, Karen Schulz3, Fred S Apple3,4.   

Abstract

AIMS: First, describe how acute myocardial infarction criteria are used to diagnose type 1 (T1MI) and 2 (T2MI) myocardial infarction. Second, determine whether subjective or objective criteria are used for T2MI. Third, examine outcomes for T2MI based on the presence or absence of objective evidence of myocardial ischemia compared with myocardial injury. METHODS AND
RESULTS: Post-hoc analysis of UTROPIA (NCT02060760), a prospective, observational, cohort study involving 1640 consecutive emergency department patients with serial high-sensitivity cardiac troponin I among whom 74 (4.5%) had T1MI, 103 (6.3%) T2MI, and 245 (15%) myocardial injury. Compared with T1MI, patients with T2MI were less likely to have ischemic symptoms (97% vs. 83%), Q waves (24% vs. 1%), new ST-T wave changes (74% vs. 51%), new regional wall motion abnormality (64% vs. 11%), and a culprit lesion on coronary angiography (59% vs. 0%) (all p <0.05). T2MIs were more likely to be diagnosed using subjective criteria (symptoms alone) than T1MI (42% vs. 12%, p <0.0001). Patients with objective T2MI, but not subjective T2MI, had a two-fold increase in early mortality compared with myocardial injury, with 30- and 60-day hazard ratios (95% confidence interval) of 2.3 (0.9, 6.2) and 2.0 (0.9, 4.7) respectively.
CONCLUSIONS: Among patients with T2MI, many cases are diagnosed using subjective criteria. The presence of objective evidence of myocardial ischemia may identify a higher-risk group of T2MI patients in whom early outcomes are worse than myocardial injury. Emphasis on using objective evidence of myocardial ischemia to diagnose T2MI may result in a more precise and specific disease definition.

Entities:  

Keywords:  Acute myocardial infarction; myocardial injury; troponin; type 2 myocardial infarction

Mesh:

Substances:

Year:  2018        PMID: 29979092     DOI: 10.1177/2048872618787796

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  7 in total

Review 1.  Type 2 Myocardial Infarction: Evolving Approaches to Diagnosis and Risk-Stratification.

Authors:  Andrew R Chapman; Yader Sandoval
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

2.  Clinical variables for predicting type-1 and type-2 non-ST segment elevation myocardial infarction in those presenting with ischemic symptoms.

Authors:  Edward T Ha; Brandon Ng; Abeer Afshaq; Eitan Fleischman; Batool Hosain; Roohi Sharma; Theodore J Gaeta; Manish Parikh; Stephen J Peterson; Wilbert S Aronow
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-07-08

3.  Assessment of Oxygen Supply-Demand Imbalance and Outcomes Among Patients With Type 2 Myocardial Infarction: A Secondary Analysis of the High-STEACS Cluster Randomized Clinical Trial.

Authors:  Anda Bularga; Caelan Taggart; Filip Mendusic; Dorien M Kimenai; Ryan Wereski; Matthew T H Lowry; Kuan K Lee; Amy V Ferry; Stacey S Stewart; David A McAllister; Anoop S V Shah; Atul Anand; David E Newby; Nicholas L Mills; Andrew R Chapman
Journal:  JAMA Netw Open       Date:  2022-07-01

4.  Does a Code for Acute Myocardial Infarction Mean the Same in All Norwegian Hospitals? A Likelihood Approach to a Medical Record Review.

Authors:  Jon Helgeland; Doris Tove Kristoffersen; Katrine Damgaard Skyrud
Journal:  Clin Epidemiol       Date:  2022-10-13       Impact factor: 5.814

5.  A systematic review on the triggers and clinical features of type 2 myocardial infarction.

Authors:  Guangqiang Wang; Na Zhao; Shu Zhong; Jianping Li
Journal:  Clin Cardiol       Date:  2019-07-11       Impact factor: 2.882

Review 6.  Diagnosis, Investigation and Management of Patients with Acute and Chronic Myocardial Injury.

Authors:  Caelan Taggart; Ryan Wereski; Nicholas L Mills; Andrew R Chapman
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

7.  Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.

Authors:  Ryan Wereski; Dorien M Kimenai; Caelan Taggart; Dimitrios Doudesis; Kuan Ken Lee; Matthew T H Lowry; Anda Bularga; David J Lowe; Takeshi Fujisawa; Fred S Apple; Paul O Collinson; Atul Anand; Andrew R Chapman; Nicholas L Mills
Journal:  Circulation       Date:  2021-06-25       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.